Clinical Trials

72 trials
RecentStart dateEnrollment
Observational × Fatigue × Clear all
NCT04806620 2026-01-22

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Brain Inflammation Collaborative

Recruiting
10,000 enrolled

Pediatric acute-onset neuropsychiatric syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections, Brain Injuries, Traumatic, Phobia, Social, Post-Lyme Disease Syndrome, Avoidant Restrictive Food Intake Disorder, Mast Cell Activation Syndrome, Neuroinflammatory Diseases, Psychological Well-Being, Post-Acute COVID-19 Syndrome, Generalized Anxiety Disorder, Anorexia Nervosa, Anxiety Disorders, Arthritis, Juvenile, Autoimmune Diseases, Autonomic Nervous System Diseases, Mental Disorders, Celiac Disease, Colitis, Ulcerative, Combat Disorders, Crohn Disease, Depression, Ehlers-Danlos Syndrome, Encephalitis, Endometriosis, Fatigue, Mental Fatigue, Fibromyalgia, Tourette Syndrome, Migraine Disorders, Multiple Sclerosis, Myasthenia Gravis, Narcolepsy, Obsessive-Compulsive Disorder, Psoriasis, Rheumatic Fever, Spondylitis, Ankylosing, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Fatigue Syndrome, Chronic, Mood Disorders, Autoimmune Diseases of the Nervous System, Bulimia Nervosa, Postural Orthostatic Tachycardia Syndrome

NCT03098589 2025-03-30

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Celgene

Completed
1,149 enrolled
Head & NeckLymphoidOther hematologic neoplasm

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis

NCT02921828 2022-07-05

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Celgene

Completed
1,149 enrolled
GenitourinaryPlasma cell

Sleepiness, Arrhythmias, Cardiac, Confusion, Consciousness Disorders, Dizziness, Fatigue, Heart Failure, Hypersensitivity, Infections, Jaundice, Liver Diseases, Multiple Myeloma, Peripheral Nervous System Diseases, Thromboembolism, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Acute Kidney Injury, Teratogenesis

NCT00477919 2019-05-15

E-MOSAIC Electronic Tool to Monitor Symptoms

Swiss Cancer Institute

Completed
264 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcomaThoracic

Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Anorexia, Bile Duct Neoplasms, Urinary Bladder Neoplasms, Body Weight Changes, Brain Neoplasms, Breast Neoplasms, Cachexia, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Depression, Esophageal Neoplasms, Fatigue, Gallbladder Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Pain, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sarcoma, Stomach Neoplasms, Gliosarcoma, Breast Neoplasms, Male, Small Cell Lung Carcinoma